A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery - the APAP trial (ISRCTN45810007)
Due to the increase of cardiovascular diseases acetylsalicylic acid (ASA) has become one of the most frequently prescribed drugs these days. Despite the rising number of patients with ASA medication presenting for elective general and abdominal surgery and the potentially increased risk of hemorrhag...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
03 March 2011
|
| In: |
BMC surgery
Year: 2011, Jahrgang: 11, Pages: 1-4 |
| ISSN: | 1471-2482 |
| DOI: | 10.1186/1471-2482-11-7 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2482-11-7
|
| Verfasserangaben: | Dalibor Antolovic, Christoph Reissfelder, Anastasia Rakow, Pietro Contin, Nuh N. Rahbari, Markus W. Büchler, Jürgen Weitz, Moritz Koch |
| Zusammenfassung: | Due to the increase of cardiovascular diseases acetylsalicylic acid (ASA) has become one of the most frequently prescribed drugs these days. Despite the rising number of patients with ASA medication presenting for elective general and abdominal surgery and the potentially increased risk of hemorrhage in these patients, there are no clear, evidence-based guidelines for the perioperative use of antiplatelet agents. The present randomised controlled trial was designed to evaluate the safety and optimize the use of ASA in the perioperative management of patients undergoing general and abdominal surgery. |
|---|---|
| Beschreibung: | Gesehen am 03.03.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1471-2482 |
| DOI: | 10.1186/1471-2482-11-7 |